Some COVID-19 vaccines are being developed using aborted human babies’ cell lines

Share:

(Natural News) Researchers around the world are rushing to come up with an effective COVID-19 vaccine, but there are lots of concerns that they will suffer from the same major flaws as many of the other vaccines we use these days, whether it’s the presence of heavy metals like mercury or aluminum, a miserable efficacy rate like the flu shot, or both. However, before any of those factors come into play, it’s the very basis of the vaccine that can be extremely questionable – especially when it comes from aborted babies.

A World Health Organization tracker shows that more than 120 vaccine candidates are currently in development, 10 of which have already moved forward to the clinical trial phase where the vaccine candidate’s efficacy and safety are being tested. More of these candidates should reach the trial phase before the close of the year.

Unfortunately, quite a few of the frontrunners are using a human fetal kidney cell line for the development of their trial vaccines. The fetal cell line is known as HEK-293, and it came from the kidney tissue of a baby girl aborted in the Netherlands in 1972. This line is being used in vaccines under development by Moderna, Inovio Pharmaceuticals, Oxford University/AstraZeneca, and CanSino Biologics/Beijing Institute of Technology.

A different human fetal cell line is being used by Janssen, the pharmaceutical division of Johnson & Johnson. The fetal cell line PER.C6 was taken from the retinal tissue of an 18-week-old boy who was aborted in 1985 in the Netherlands.

Much of this vaccine development is being funded by grants from the U.S. government. So far, nearly $2 billion has gone to support the development of vaccines for COVID-19 that use fetal cell lines. A lot of this funding is being awarded through a division of the Department of Health and Human Services called the Biomedical Advanced Research and Development Authority (BARDA).